Breaking News
Dilbert Creator Scott Adams on Climate: "Hockey Stick is a Symbol of Lying"
Existing Home Sales Down Again: -1.2% Month Over Month, -8.5% Year-Over-Year
Raw Politics: Hungary Prime Minister Attacks Juncker and Soros in Billboard Ad
If Truth Is Politicized, All Is Lost
Top Tech News
Moon Bases, Orbital Bases and the Start of Mars Colonization by 2040
LinkedIn Launches a Live Video Streaming Service
Sirin Labs Finney Blockchain Phone
Converting cells into new neurons could lead to a pill that repairs brain damage
Elon Musk and Others Plan the Details for a City on Mars
Tesla Acquires Maxwell Technologies for Battery Breakthrough
IBM Investing $2 Billion in an AI Center and Targets 1000 Times Improvement by 2029
Raspberry Pi opens first bricks and mortar store
Car-jack-on-steroids exposes vehicles' underbellies
Nikola Announces All-Electric Semi Truck: Up To 1,000-kWh Battery
Anti-Aging Researcher David Sinclair Takes Metformin, NMN, NAD for Longevity
In 2013, GlaxoSmithKline shutdown Sirtris (David Sinclair's company) about five years after spending $720 million to buy Sirtris.
David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
Life Biosciences was co-founded in 2017 by David A. Sinclair, PhD, AO, a professor in the Department of Genetics at Harvard Medical School, and Tristan Edwards, an investment professional who developed its innovative company structure.